1Department of Nutrition and Food Hygiene, School of Public Health, Soochow University, Suzhou, China.
2Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY.
Diabetes Care. 2022 Jan 1;45(1):222-231. doi: 10.2337/dc21-1565.
To assess the relationship between body fat distribution and incident lower-extremity arterial disease (LEAD).
We included 155,925 postmenopausal women with anthropometric measures from the Women's Health Initiative who had no known LEAD at recruitment. A subset of 10,894 participants had body composition data quantified by DXA. Incident cases of symptomatic LEAD were ascertained and adjudicated through medical record review.
We identified 1,152 incident cases of LEAD during a median 18.8 years follow-up. After multivariable adjustment and mutual adjustment, waist and hip circumferences were positively and inversely associated with risk of LEAD, respectively (both P-trend < 0.0001). In a subset (n = 22,561) where various cardiometabolic biomarkers were quantified, a similar positive association of waist circumference with risk of LEAD was eliminated after adjustment for diabetes and HOMA of insulin resistance (P-trend = 0.89), whereas hip circumference remained inversely associated with the risk after adjustment for major cardiometabolic traits (P-trend = 0.0031). In the DXA subset, higher trunk fat (P-trend = 0.0081) and higher leg fat (P-trend < 0.0001) were associated with higher and lower risk of LEAD, respectively. Further adjustment for diabetes, dyslipidemia, and blood pressure diminished the association for trunk fat (P-trend = 0.49), yet the inverse association for leg fat persisted (P-trend = 0.0082).
Among U.S. postmenopausal women, a positive association of upper-body fat with risk of LEAD appeared to be attributable to traditional risk factors, especially insulin resistance. Lower-body fat was inversely associated with risk of LEAD beyond known risk factors.
评估体脂分布与下肢动脉疾病(LEAD)发病之间的关系。
我们纳入了 155925 名参加妇女健康倡议的绝经后妇女,她们在招募时没有已知的 LEAD。10894 名参与者的身体成分数据通过 DXA 进行了定量分析。通过病历审查确定并裁定症状性 LEAD 的发病情况。
在中位数为 18.8 年的随访期间,我们发现了 1152 例 LEAD 发病病例。经过多变量调整和相互调整后,腰围和臀围与 LEAD 的发病风险呈正相关和负相关(均 P-trend < 0.0001)。在一个(n = 22561)量化了各种心血管代谢生物标志物的亚组中,腰围与 LEAD 发病风险的正相关在调整糖尿病和胰岛素抵抗的 HOMA 后被消除(P-trend = 0.89),而臀围在调整主要心血管代谢特征后仍与风险呈负相关(P-trend = 0.0031)。在 DXA 亚组中,较高的躯干脂肪(P-trend = 0.0081)和较高的腿部脂肪(P-trend < 0.0001)分别与 LEAD 的较高和较低风险相关。进一步调整糖尿病、血脂异常和血压使躯干脂肪的相关性减弱(P-trend = 0.49),但腿部脂肪的负相关仍然存在(P-trend = 0.0082)。
在美国绝经后妇女中,上半身脂肪与 LEAD 发病风险的正相关似乎归因于传统危险因素,尤其是胰岛素抵抗。下半身脂肪与 LEAD 发病风险呈负相关,超出了已知的危险因素。